Publications by authors named "Maria Piedad Ussetti Gil"
(1) The prevention of cytomegalovirus (CMV) in lung transplant recipients (LTx) is based on the administration of VGC for a period of 6-12 months, but there is little information on the premature discontinuation of the drug. Our objective was to evaluate the reasons for early cessation of VGC and the dynamics of CMV replication after discontinuation. (2) We carried out a retrospective study of LTx on VGC prophylaxis according to guidelines, with an outpatient follow-up period of >90 days.
View Article and Find Full Text PDFArticle Synopsis
- Neutropenia frequently occurs in solid organ transplant recipients, particularly lung transplant patients, with this study analyzing its impact post-transplant for up to 18 months after surgery.
- Over half of the 305 patients studied experienced neutropenia, with most cases being mild, and about a quarter required granulocyte colony-stimulating factor (GCSF) treatment.
- While neutropenia didn’t significantly affect acute rejection, chronic lung allograft dysfunction, or overall survival, those treated with GCSF showed a higher mortality rate, and a small percentage developed infections during episodes of neutropenia.
Unlabelled: Previous studies in solid organ transplantation have shown a relationship between circulating eosinophil (EOS) counts and the presence of acute cellular rejection (ACR). However, the relationship between this potential biomarker and ACR in lung transplant (LTx) patients remains unclear.
Objective: To assess the association between EOS and the presence of acute cellular rejection in lung transplant recipients.